- Patient/Guest
- Phlebotomist
- Updates
| Myeloma Protein Basic | - |
|---|
|
Measure basic myeloma proteins |
||
| Synonym | See updates | |
| Test Code | CDBIOPR0044 | |
| Test Type | Biochemistry | |
| Pre-Test Condition | See updates | |
| Report Availability | 3 D(s) | |
| # Test(s) | Multiple | |
| Test details | Sample Report |
|---|---|
| Myeloma Protein Basic |
|
| Synonym | See updates | ||
| Test Code | CDBIOPR0044 | ||
| Test Category | Multiple myeloma | ||
| Pre-Test Condition | See updates | ||
| |
Medical History | See updates | |
| Report Availability | 3 D(s) | ||
| Specimen/Sample | Serum; 2 mL; SST | ||
| Stability @21-26 deg. C | 6 Hr(s) | ||
| Stability @ 2-8 deg. C | 7 D(s) | ||
| Stability @ Frozen | 1 M(s) | ||
| # Test(s) | Multiple | ||
| Processing Method | Electrophoresis | ||
| **Multiple Myeloma Protein Profile Basic****FDA Status**: FDA-approved for myeloma diagnostics.**Other Names**: Myeloma Protein Panel, SPEP/UPEP Testing.**Historical Breakthrough**: Developed in the 1960s for myeloma diagnosis, advancing hematology.**Key Purpose and Impact**: Uses SPEP, UPEP, and immunofixation to detect monoclonal proteins in multiple myeloma.**Preparation and Patient History**: Blood and urine; report bone pain, anemia, or myeloma history.**Consent Requirement**: Standard consent for blood and urine collection.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects myeloma in ~90% of cases; guides diagnosis.**References Cited**: Testing.com Myeloma Tests 2023; Labcorp Myeloma Panel 2025; UpToDate Multiple Myeloma 2025 |
